ADMA Biologics ADMA Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on trailing twelve months.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's free cash flow yield?
- ADMA Biologics (ADMA) reported free cash flow yield of 5% in Q1 2026.
- How has ADMA Biologics's free cash flow yield changed year-over-year?
- ADMA Biologics's free cash flow yield increased by 161.5% year-over-year, from 1.9% to 5%.
- What is the long-term trend for ADMA Biologics's free cash flow yield?
- Over 5 years (2020 to 2025), ADMA Biologics's free cash flow yield has grown at a -53.7% compound annual growth rate (CAGR), from -30% to 0.6%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.